Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Linking KSHV to human cancer.

Emily L Wong1, Blossom Damania

  • 1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Current Oncology Reports
|August 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

SFPQ prevents MDA5-mediated activation of innate immunity and preserves cell viability.

Cell reports·2026
Same author

Withaferin A inhibits EBV-driven lymphomagenesis through multiple mechanisms, including EBNA1 degradation.

Blood·2025
Same author

cGAS Inhibits ALDH2 to Suppress Lipid Droplet Function and Regulate MASLD Progression.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

KSHV and HPV modulate epithelial-to-mesenchymal transition in oral epithelial cells.

mBio·2025
Same author

Innate Immune Recognition of EBV.

Current topics in microbiology and immunology·2025

Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, causes Kaposi's sarcoma and other cancers. This review covers KSHV's role in malignancies, relevant genes, and treatment options.

Area of Science:

  • Virology
  • Oncology
  • Infectious Diseases

Background:

  • Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is implicated in several human malignancies.
  • KSHV is the causative agent for Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's disease (MCD).

Purpose of the Study:

  • To review the association between KSHV and human cancers.
  • To identify viral genes potentially involved in KSHV-associated neoplastic processes.
  • To summarize current therapeutic strategies for KSHV-related diseases.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of KSHV's role as an etiologic agent.
  • Examination of viral gene functions in oncogenesis.

Related Experiment Videos

Main Results:

  • KSHV is a double-stranded DNA gammaherpesvirus.
  • Specific KSHV genes are under investigation for their oncogenic potential.
  • Established therapies exist for KS, PEL, and MCD.

Conclusions:

  • KSHV is a significant factor in the pathogenesis of KS, PEL, and MCD.
  • Understanding KSHV's viral genes is crucial for developing targeted therapies.
  • Current treatments aim to manage KSHV-driven malignancies.